SEARCH

SEARCH BY CITATION

References

  • Beelen, D.W., Graeven, U., Elmaagacli, A.H., Niederle, N., Kloke, O., Opalka, B., Schaefer, U.W. (1995) Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome. Blood, 85, 29812990.
  • Bornhauser, M., Thiede, C., Schuler, U., Platzbecker, U., Frieberg-Richter, J., Helwig, A., Plettig, R., Rollig, C., Naumann, R., Kroschinsky, F., Neubauer, A., Ehningher, G. (2000) Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin. Bone Marrow Transplantation, 26, 119125.
  • Carella, A.M., Giralt, S., Slavin, S. (2000a) Low intensity regimens with allogeneic hematopoietic stem cell transplantation as treatment of hematologic neoplasia. Haematologica, 85, 304313.
  • Carella, A.M., Champlin, R., Slavin, S., McSweeney, P., Storb, R. (2000b) Mini-allografts: ongoing trials in humans. Bone Marrow Transplantation, 25, 345350.
  • Childs, R., Epperson, D., Bahceci, E., Clave, E., Barrett, J. (1999) Molecular remission of chronic myeloid leukaemia following a non-myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitro evidence for a graft-versus-leukaemia effect. British Journal of Haematology, 107, 396400.
  • Giralt, S., Szydlo, R., Goldman, J.M., Veum-Stone, J., Biggs, J.C., Herzig, R.H., Klein, J.P., McGlave, P.B., Schiller, G., Gale, R.P., Rowlings, P.A., Horowitz, M.M. (2000) Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the International Bone Marrow Transplant Registry. Blood, 95, 410415.
  • Giralt, S.A., Kantarjian, H.M., Talpaz, M., Rios, M.B., Del Giglio, A., Andersson, B.S., Przepiorka, D., Deisseroth, A.B., Champlin, R.E. (1993) Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia. Journal of Clinical Oncology, 11, 10551061.
  • Gomez-Almaguer, D., Ruiz-Arguelles, G.J., Ruiz-Arguelles, A., Gonzalez-Llano, O., Cantu, O.E., Hernandez, N.E. (2000) Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: report of four cases. Bone Marrow Transplantation, 25, 131133.
  • Gratwohl, A., Hermans, J., Niederwieser, D., Frassoni, F., Arcese, W., Gahrton, G., Bandini, G., Carreras, E., Vernant, J.P., Bosi, A., De Witte, T., Fibbe, W.E., Zwaan, F., Michallet, M., Ruutu, T., Devergie, A., Iriando, A., Apperley J., Reiffers, J., Speck, B., Goldman, J. for the chronic leukaemia Working Party of the EMBT (1993) Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation. Bone Marrow Transplantation, 12, 509516.
  • Gratwohl, A., Hermans, J., Goldman, J.M., Arcese, W., Carreras, E., Devergie, A., Frassoni, F., Gahrton, G., Kolb, H.J., Niederwieser, D., Ruutu, T., Vernant, J.P., De Witte, T., Apperley, J. (1998) Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet, 352, 10871092.DOI: 10.1016/S0140-6736(98)03030-X
  • Grigg, A., Bardy, P., Byron, K., Seymour, J.F., Szer, J. (1999) Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma. Bone Marrow Transplantation, 23, 107110.
  • Hasford, J., Pfirrmann, M., Hehlmann, R., Allan, N.C., Baccarini, M., Kluin-Nelemans, J.C., Alimena, G., Steegmann, J.L., Ansari, H. (1998) A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon-alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group. Journal of the National Cancer Institute, 90, 850858.DOI: 10.1093/jnci/90.11.850
  • Hehlmann, R., Hochhaus, A., Kolb, H.J., Hasford, J., Gratwohl, A., Heimpel, H., Siegert, W., Finke, J., Ehninger, G., Holler, E., Berger, U., Pfirrmann, M., Muth, A., Zander, A., Fauser, A.A., Heyll, A., Nerl, C., Hossfeld, D.K., Loffler, H., Pralle, H., Queisser, W., Tobler, A. (1999) Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure. Blood, 94, 36683677.
  • Kaplan, E. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistics Association, 53, 457462.
  • Khouri, I.F., Keating, M., Korbling, M., Przepiorka, D., Anderlini, P., O'Brien, S., Giralt, S., Ippoliti, C., Von Wolff, B., Gajewski, J., Donato, M., Claxton, D., Ueno, N., Andersson, B., Gee, A., Champlin, R. (1998) Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. Journal of Clinical Oncology, 16, 28172824.
  • Kiss, T.L., Xu, W.M., Jamal, N., Messner, H.A. (1999) Comparative testing of peripheral blood and bone marrow for BCR-ABL transcripts in patients post allogeneic bone marrow transplantation and during interferon treatment for chronic myeloid leukemia. Leukaemia and Lymphoma, 34, 493500.
  • Kolb, H.J., Schattenberg, A., Goldman, J.M., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., Niederwieser, D. (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood, 86, 20412050.
  • Morariu-Zamfir, R., Rocha, V., Devergie, A., Socie, G., Ribaud, P., Esperou H., Parquet N., Guardiola P., Dal Cortivo, L., Bittencourt, H., Garnier, F., Traineau, R., Marolleau, J.P., Chevret, S., Gluckman, E. (2001) Influence of CD34(+) marrow cell ose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia. Bone Marrow Transplantation, 27, 575580.
  • Morton, A.J., Gooley, T., Hansen, J.A., Appelbaum, F.R., Bruemmer, B., Bjerke, J.W., Clift, R., Martin, P.J., Petersdorf, E.W., Sanders, J.E., Storb, R., Sullivan, K.M., Woolfrey, A., Anasetti, C. (1998) Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase. Blood, 92, 394401.
  • Nagler, A., Slavin, S., Varadi, G., Naparstek, E., Samuel, S., Or, R. (2000) Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma. Bone Marrow Transplantation, 25, 10211028.
  • Najfeld, V., Burnett, W., Vlachos, A., Scigliano, E., Isola, L., Fruchtman, S. (1997) Interphase FISH analysis of sex-mismatched BMT utilizing dual color XY probes. Bone Marrow Transplantation, 19, 829834.
  • Petrus, M.J., Williams, J.F., Eckhaus, M.A., Gress, R.E., Fowler, D.H. (2000) An immunoablative regimen of fludarabine and cyclophosphamide prevents fully MHC-mismatched murine marrow graft rejection independent of GVHD. Biology of Blood and Marrow Transplantation, 6, 182189.
  • Porter, D.L. & Antin, J.H. (1999) The graft-versus-leukemia effects of allogeneic cell therapy. Annual Review of Medicine, 50, 369386.
  • Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H.G., Beatty, P., Hows, J., Thomas, E.D. (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplantation, 15, 825828.
  • Przepiorka, D., Smith, T.L., Folloder, J., Khouri, I., Ueno, N.T., Mehra, R., Korbling, M., Huh, Y.O., Giralt, S., Gajewski, J., Donato, M., Cleary, K., Claxton, D., Braunschweig, I., Van Besien, K., Andersson, B.S., Anderlini, P., Champlin, R. (1999) Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood, 94, 14651470.
  • Singhal, S., Powles, R., Treleaven, J., Kulkarni, S., Sirohi, B., Horton, C., Millar, B., Shepherd, V., Tait, D., Saso, R., Rowland, A., Long, S., Mehta, J. (2000) A low CD34+ cell dose results in higher mortality and poorer survival after blood or bone marrow stem cell transplantation from HLA-identical siblings: should 2 x 106 CD34+ cells/kg be considered the minimum threshold? Bone Marrow Transplantation, 26, 489496.
  • Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., Amar, A., Brautbar, C., Ben-Tal, O., Eldor, A., Or, R. (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood, 91, 756763.
  • Thiede, C., Florek, M., Bornhauser, M., Ritter, M., Mohr, B., Brendel, C., Ehninger, G., Neubauer, A. (1999) Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplantation, 23, 10551060.
  • Tomas, J.F., Lopez-Lorenzo, J.L., Requena, M.J., Aguilar, R., Steegmann, J.L., Camara, R., Alegre, A., Arranz, R., Figuera, A., Fernandez-Ranada, J.M. (1998) Absence of influence of prior treatment with interferon on the outcome of allogeneic bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplantation, 22, 4751.
  • Zuffa, E., Bandini, G., Bonini, A., Santucci, M.A., Martinelli, G., Rosti, G., Testoni, N., Zaccaria, A., Tura, S. (1998) Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia. Haematologica, 83, 231236.